Short answer
No cannabis product is FDA-approved to treat osteoarthritis. Reviews find weak evidence for cannabinoids in joint pain. Some people with knee or hip OA report less pain after using THC or CBD. The data come from surveys, small trials, and studies of chronic pain in general. A doctor in a medical cannabis state can certify OA pain as a qualifying condition when standard drugs fail or cause side effects.
related article
What osteoarthritis is
Osteoarthritis breaks down cartilage and changes the bone beneath it. It affects about 32.5 million US adults. The knee is the most common site. Symptoms are joint pain that worsens with use, stiffness after rest that lasts under 30 minutes, and reduced range of motion.
best cannabis products for rheumatoid arthritis
Risk factors include age over 45, obesity, past joint injury, repetitive joint loading, and family history. Cartilage has no nerve endings. Pain signals come from the joint capsule, synovium, bone marrow lesions, and nearby muscle.
Does Cannabis Reduce Inflammation in Arthritis? A Practical Guide
Standard treatment
Guidelines from the American College of Rheumatology and OARSI list:
- Topical NSAIDs for knee OA
- Oral NSAIDs at the lowest effective dose
- Acetaminophen, with small effect sizes
- Exercise, weight loss, physical therapy
- Duloxetine for widespread pain
- Steroid injections into the joint for flares
- Joint replacement for advanced disease
Cannabis fills a gap for patients who cannot take NSAIDs or opioids. It is not a first-line option.
Evidence on cannabis and OA
The 2017 National Academies report found conclusive evidence that cannabis treats chronic pain in adults. That report found no study that isolates osteoarthritis as an outcome. A 2018 Cochrane review rated cannabis-based medicines for chronic pain as low quality evidence.
Joint-specific studies are few. Trials of topical CBD for knee OA have sample sizes under 100 people. Some showed pain reduction. Others showed no difference from placebo. No head-to-head trial compares cannabis with NSAIDs for OA. Clinic surveys report that about 1 in 5 rheumatology patients has used cannabis for symptoms. Surveys cannot show cause and effect.
How cannabinoids act on joints
THC binds CB1 receptors in the brain and spinal cord. That changes pain signaling and produces euphoria. CBD binds CB1 and CB2 with low affinity and blunts some THC effects. CB2 receptors sit on immune cells and synovial tissue, which is where an anti-inflammatory effect would matter in OA. Most CBD anti-inflammatory data comes from lab dishes and animal models, not human joints.
Product forms and onset
- Inhaled flower or vape: onset 2 to 10 minutes, effects last 1 to 3 hours
- Oral capsule, edible, or tincture: onset 30 to 120 minutes, effects last 4 to 8 hours
- Topical cream, balm, or patch: onset 15 to 60 minutes, little to no psychoactivity
Topicals are the lowest-risk option for one knee. Skin absorption is limited, so blood levels stay low.
Dosing
No standard dose exists. Federal prohibition blocks the trials needed to set one. Clinical advice follows the same pattern:
- Start at 2.5 mg THC or less.
- Wait 2 hours before adding more.
- Raise the dose by 2.5 mg every 2 to 3 days.
- Stop at the dose that lowers pain without heavy sedation or anxiety.
CBD doses in published trials range from 5 mg to 50 mg per day. Higher doses cost more and have not shown better joint results.
Risks and interactions
Side effects include dizziness, drowsiness, dry mouth, fast heart rate, impaired memory, and anxiety at high THC doses.
Cannabis use disorder occurs in about 9% of adults who use cannabis. The rate rises to about 17% for people who start in their teens.
CBD inhibits the CYP3A4 and CYP2C19 enzymes. That can raise blood levels of warfarin, clopidogrel, some statins, and tacrolimus. Ask a pharmacist to screen the full drug list.
Smoked cannabis irritates airways. THC impairs driving for several hours. Older adults face a higher fall risk from sedation.
Legal status in the US
Federal law lists cannabis as a Schedule I drug. The FDA has approved no marijuana product for OA. More than 35 states run medical cannabis programs. OA pain usually qualifies under a chronic pain clause. Recertification runs every 6 to 12 months, set by each state.
How to get a certification
- Check the state qualifying condition list.
- Bring imaging, a diagnosis, and a list of drugs already tried to a certifying clinician.
- Ask the dispensary for a batch label with THC, CBD, pesticide, and mold test results.
- Keep one product for 2 weeks before switching.
- Log pain score, sleep hours, and side effects.
Bottom line
The evidence for cannabis in osteoarthritis is weak. Topicals carry the least risk. Oral THC helps some patients with chronic pain. Talk to the clinician who manages the joint and to the clinician who signs the card.